28 related articles for article (PubMed ID: 10234297)
1. Preservation of Erectile and Ejaculatory Functions After Tetramodal Bladder-Sparing Therapy Incorporating Consolidative Partial Cystectomy Against Muscle Invasive Bladder Cancer.
Uchida Y; Yokoyama M; Fujiwara M; Nakamura Y; Ishikawa Y; Fukuda S; Waseda Y; Tanaka H; Yoshida S; Fujiwara T; Fujii Y
Urol Res Pract; 2023 May; 49(3):162-168. PubMed ID: 37877865
[TBL] [Abstract][Full Text] [Related]
2. Factors contributing to the ceiling effect of the EQ-5D-5L: an analysis of patients with prostate cancer judged "no-problems".
Murasawa H; Sugiyama T; Matsuoka Y; Okabe T; Wakumoto Y; Tanaka N; Sugimoto M; Oyama M; Fujimoto K; Horie S; Funagoshi M; Arakawa I; Noto S; Shimozuma K
Qual Life Res; 2020 Mar; 29(3):755-763. PubMed ID: 31583618
[TBL] [Abstract][Full Text] [Related]
3. Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: a randomized controlled phase II a trial.
Fujimura T; Takahashi S; Kume H; Urano T; Takayama K; Yamada Y; Suzuki M; Fukuhara H; Nakagawa T; Inoue S; Homma Y
BMC Cancer; 2015 Nov; 15():836. PubMed ID: 26526623
[TBL] [Abstract][Full Text] [Related]
4. Reliability and Validity of the Chinese Version of FACIT-AI, a New Tool for Assessing Quality of Life in Patients with Malignant Ascites.
Lou Y; Lu L; Li Y; Liu M; Bredle JM; Jia L
J Palliat Med; 2015 Oct; 18(10):829-33. PubMed ID: 26177329
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of quality of life in patients with previously untreated advanced prostate cancer receiving maximum androgen blockade therapy or LHRHa monotherapy: a multicenter, randomized, double-blind, comparative study.
Arai Y; Akaza H; Deguchi T; Fujisawa M; Hayashi M; Hirao Y; Kanetake H; Naito S; Namiki M; Tachibana M; Usami M; Ohashi Y
J Cancer Res Clin Oncol; 2008 Dec; 134(12):1385-96. PubMed ID: 18491137
[TBL] [Abstract][Full Text] [Related]
6. [Quality of life after radical urologic pelvic surgery and impact of inpatient rehabilitation].
Dombo O; Otto U
Urologe A; 2005 Jan; 44(1):11-28. PubMed ID: 15619061
[TBL] [Abstract][Full Text] [Related]
7. Participation behavior of bladder cancer survivors in a medical follow-up survey on quality of life in France.
Matsuda T; Marche H; Grosclaude P; Clement S
Eur J Epidemiol; 2004; 19(4):313-21. PubMed ID: 15180101
[TBL] [Abstract][Full Text] [Related]
8. Quality of life aspects of bladder cancer: a review of the literature.
Botteman MF; Pashos CL; Hauser RS; Laskin BL; Redaelli A
Qual Life Res; 2003 Sep; 12(6):675-88. PubMed ID: 14516177
[TBL] [Abstract][Full Text] [Related]
9. Measuring quality of life in patients with melanoma: development of the FACT-melanoma subscale.
Cormier JN; Davidson L; Xing Y; Webster K; Cella D
J Support Oncol; 2005; 3(2):139-45. PubMed ID: 15796446
[TBL] [Abstract][Full Text] [Related]
10. [Development of Japanese version of QOL questionnaire for bladder and prostate cancer patients using FACT-Bl and P: pilot study].
Hinotsu A; Niimi M; Akaza H; Miyanaga N; Takeshima H; Eremenco S; Cella D
Gan To Kagaku Ryoho; 1999 Apr; 26(5):657-66. PubMed ID: 10234297
[TBL] [Abstract][Full Text] [Related]
11. [The critical appraisal of QOL questionnaire for prostate cancer patients].
Niimi M; Takeshima H; Hinotsu A; Takahashi H; Kano K; Otani M; Ishikawa S; Noguchi R; Oda E; Ohashi Y; Akaza H
Gan To Kagaku Ryoho; 1999 Feb; 26(3):333-43. PubMed ID: 10065097
[TBL] [Abstract][Full Text] [Related]
12. [Assessment of quality of life as an endpoint of cancer treatment].
Hinotsu A; Akaza H
Gan To Kagaku Ryoho; 2000 May; 27(5):676-82. PubMed ID: 10832434
[TBL] [Abstract][Full Text] [Related]
13. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument.
Esper P; Mo F; Chodak G; Sinner M; Cella D; Pienta KJ
Urology; 1997 Dec; 50(6):920-8. PubMed ID: 9426724
[TBL] [Abstract][Full Text] [Related]
14. Health related quality of life after orthotopic neobladder construction and its comparison with normative values in the Japanese population.
Yoneda T; Adachi H; Urakami S; Kishi H; Shigeno K; Shiina H; Igawa M
J Urol; 2005 Nov; 174(5):1944-7. PubMed ID: 16217363
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
